A Single-arm Study of Toripalimab in Adjuvant Therapy After Resection of High-risk Renal Cancer Tumors
Latest Information Update: 09 Sep 2024
At a glance
- Drugs Toripalimab (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- Acronyms TUOAD-RCC
- 09 Sep 2024 New trial record